These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 7108595)

  • 1. Synergistic effect of perfluorochemicals on BCNU chemotherapy. Experimental study in a 9L rat brain-tumor model.
    Kuwamura K; Kokunai T; Tamaki N; Matsumoto S
    J Neurosurg; 1982 Oct; 57(4):467-71. PubMed ID: 7108595
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Possibility of the use of perfluorochemicals (fluorocarbons) as adjuvants in chemotherapy of cancer].
    Kuwamura K; Kokunai T
    Gan To Kagaku Ryoho; 1982 Jul; 9(7):1256-61. PubMed ID: 7184453
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Effect of perfluorochemicals on BCNU chemotherapy in a rat brain-tumor model].
    Kokunai T; Kuwamura K
    No To Shinkei; 1982 Jun; 34(6):609-15. PubMed ID: 7115598
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of Fluosol-DA on the response of intracranial 9L tumors to X rays and BCNU.
    Teicher BA; Herman TS; Rose CM
    Int J Radiat Oncol Biol Phys; 1988 Nov; 15(5):1187-92. PubMed ID: 3141321
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Potentiation of rat brain tumor therapy by fluosol and carbogen.
    Martin DF; Kimler BF; Evans RG; Morantz RA; Vats TS
    NCI Monogr; 1988; (6):119-22. PubMed ID: 3127732
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of perfluorochemicals on BCNU chemotherapy: preliminary study in a rat brain tumor model.
    Kokunai T; Kuwamura K
    Surg Neurol; 1982 Oct; 18(4):258-61. PubMed ID: 7179085
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of surgery on BCNU chemotherapy in a rat brain tumor model.
    Tel E; Hoshino T; Barker M; Wilson CB
    J Neurosurg; 1980 Apr; 52(4):529-32. PubMed ID: 7373376
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Increased tumor cures using combined radiosurgery and BCNU in the treatment of 9l glioma in the rat brain.
    Khil MS; Kolozsvary A; Apple M; Kim JH
    Int J Radiat Oncol Biol Phys; 2000 May; 47(2):511-6. PubMed ID: 10802380
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Synergism between BCNU and irradiation in the treatment of anaplastic gliomas. An in vivo study using the avian sarcoma virus-induced glioma model.
    Steinbok P; Mahaley MS; U R; Zinn DC; Lipper S; Mahaley JL; Bigner DD
    J Neurosurg; 1979 Nov; 51(5):581-6. PubMed ID: 228015
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Treatment of recurrent malignant glioma with BCNU-fluosol and oxygen inhalation. A phase I-II study.
    Hochberg F; Prados M; Russell C; Weissman D; Evans R; Cook P; Burton G; Eisenberg PD; Valenzuela R; Verkh L
    J Neurooncol; 1997 Mar; 32(1):45-55. PubMed ID: 9049862
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of fluosol-DA/carbogen on etoposide/alkylating agent antitumor activity.
    Teicher BA; Bernal SD; Holden SA; Cathcart KN
    Cancer Chemother Pharmacol; 1988; 21(4):281-5. PubMed ID: 3131032
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Potentiation of the antitumor therapeutic effects of 1,3-bis(2-chloroethyl)-1-nitrosourea by alpha-difluoromethylornithine, an ornithine decarboxylase inhibitor.
    Marton LJ; Levin VA; Hervatin SJ; Koch-Weser J; McCann PP; Sjoerdsma A
    Cancer Res; 1981 Nov; 41(11 Pt 1):4426-31. PubMed ID: 6796258
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Effect of perfluorochemicals on BCNU chemotherapy in a 9L rat brain tumor model].
    Kokunai T; Kuwamura K
    Neurol Med Chir (Tokyo); 1982 Oct; 22(10):777-83. PubMed ID: 6185861
    [No Abstract]   [Full Text] [Related]  

  • 14. The role of minocycline in the treatment of intracranial 9L glioma.
    Weingart JD; Sipos EP; Brem H
    J Neurosurg; 1995 Apr; 82(4):635-40. PubMed ID: 7897527
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fluosol-DA/carbogen with lonidamine or pentoxifylline as modulators of alkylating agents in the FSaIIC fibrosarcoma.
    Teicher BA; Herman TS; Tanaka J; Dezube B; Pardee A; Frei E
    Cancer Chemother Pharmacol; 1991; 28(1):45-50. PubMed ID: 1904012
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of alpha-difluoromethylornithine on the growth of 9L rat brain tumor multicellular spheroids and their response to 1,3-bis(2-chloroethyl)-1-nitrosourea.
    Sano Y; Deen DF; Oredsson SM; Marton LJ
    Cancer Res; 1984 Feb; 44(2):577-81. PubMed ID: 6420048
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effectiveness of controlled release of a cyclophosphamide derivative with polymers against rat gliomas.
    Judy KD; Olivi A; Buahin KG; Domb A; Epstein JI; Colvin OM; Brem H
    J Neurosurg; 1995 Mar; 82(3):481-6. PubMed ID: 7861228
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Improved treatment of a brain-tumor model. Part 2: Sequential therapy with BCNU and 5-fluorouracil.
    Gerosa MA; Dougherty DV; Wilson CB; Rosenblum ML
    J Neurosurg; 1983 Mar; 58(3):368-73. PubMed ID: 6827321
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Synergistic cytotoxicity of the ribonucleotide reductase inhibitor didox (3,4-dihydroxy-benzohydroxamic acid) and the alkylating agent carmustine (BCNU) in 9L rat gliosarcoma cells and DAOY human medulloblastoma cells.
    Horvath Z; Höchtl T; Bauer W; Fritzer-Szekeres M; Elford HL; Szekeres T; Tihan T
    Cancer Chemother Pharmacol; 2004 Aug; 54(2):139-45. PubMed ID: 15133626
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of difluoromethylornithine on the antiglioma therapeutic efficacy of intra-arterial BCNU.
    Cohen AR; Pietronigro DD; Cravioto H; Flamm ES
    J Neurosurg; 1986 Nov; 65(5):671-8. PubMed ID: 3095505
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.